Skip to main content
. 2022 Feb 4;5(1):61–90. doi: 10.3138/canlivj-2021-0030

Figure 7:

Figure 7:

Targets of NASH therapy

NASH = Non-alcoholic steatohepatitis; OCA = Obeticholic acid; FXR = Farnesoid X receptors; FGF19 = Fibroblast growth factor 19; GLP-1 = Glucagon-like peptide 1; SGLT-2 = Sodium-glucose transport protein 2; THR = Thyroid hormone receptor; PPAR = Peroxisome proliferator-activated receptors